Analyst Ratings for Threshold Pharmaceuticals (THLD) [Buys]
THLD Rating Summary
THLD Price Target Summary
- Highest: $15.00 (Lazard Capital)
- Lowest: $10.00 (Maxim Group)
- Average: $12.86
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.86 (+132.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/20/2013 | Piper Jaffray | Upgrade | Overweight (Neutral) |
10.00 (5.00) |
4.46 | 5.54 | 24.22% | Details |
| 11/21/2012 | Brean Capital | New Coverage | Buy (N/A) |
15.00 (N/A) |
4.63 | 5.54 | 19.65% | Details |
| 9/20/2012 | Maxim Group | New Coverage | Buy (N/A) |
10.00 (N/A) |
7.78 | 5.54 | -28.79% | Details |
| 8/24/2012 | Stifel Nicolaus | New Coverage | Buy (N/A) |
13.00 (N/A) |
7.43 | 5.54 | -25.44% | Details |
| 7/10/2012 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
8.15 | 5.54 | -32.02% | Details |
| 4/2/2012 | Mizuho Securities | New Coverage | Buy (N/A) |
15.00 (N/A) |
8.80 | 5.54 | -37.05% | Details |
| 4/1/2011 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
1.54 | 5.54 | 259.74% | Details |
